Anixa Biosciences is trading at $3.78, up 5.22%, amid broader global risk-on sentiment.

  • U.S. futures point higher; the Nasdaq Composite is up 0.62%.
  • Searches found no fresh company-specific announcement on August 21, 2026.
  • Latest official releases concern earlier clinical, patent, and conference updates; the catalyst appears primarily global, though confidence is limited.